Sanofi (France)
NEWS
The company eleased the pipeline update at its Q4 earnings report.
According to sources reported by Reuters, potential buyers have been winnowed down to two pharma companies, three private equity funds, and a consortium of buyers.
Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi.
The SEC filed a suit against “one or more unknown traders” while it seeks to identify the perpetrators.
Only a week after Sanofi ponied up $11.6B to buy Waltham, Massachusetts-based Bioverativ, the French drugmaker is buying Ghent, Belgium-based Ablynx for $4.8B.
We are still only in January and Celgene and Sanofi have already made a combined $20B in M&A deals.
Sanofi has announced major restructuring, which will involve about 400 job cuts in the U.S.
Sanofi has announced major restructuring, which will involve layoffs.
The deal has Sanofi paying $105 per share in cash.
JOBS
IN THE PRESS